A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes
Condition:   Genital Herpes Interventions:   Biological: mRNA-1608;   Biological: BEXSERO Sponsor:   ModernaTX, Inc. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 13, 2023 Category: Research Source Type: clinical trials

Knowledge of Young Adults About Genital Herpes
Condition:   Genital Herpes Intervention:   Other: data collection Sponsor:   Université de Reims Champagne-Ardenne Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 9, 2023 Category: Research Source Type: clinical trials